Title : Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemia.

Pub. Date : 2004 Mar

PMID : 15024300






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 All doses of rosuvastatin significantly reduced levels of atherogenic lipoprotein and apolipoproteins over placebo, including low-density lipoprotein cholesterol, total cholesterol, non-high-density lipoprotein cholesterol, very-low-density lipoprotein cholesterol, apolipoprotein B and apolipoprotein C-III. Rosuvastatin Calcium apolipoprotein B Homo sapiens